About 2-[3-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]oxybenzene-2-id-1-yl]quinoline;N-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]-N-phenyl-3-quinolin-2-ylbenzene-2-id-1-amine;2-[3-[2-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]propan-2-yl]benzene-2-id-1-yl]quinoline;2-[3-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]sulfanylbenzene-2-id-1-yl]quinoline;tetrakis(platinum(2+))
2-[3-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]oxybenzene-2-id-1-yl]quinoline;N-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]-N-phenyl-3-quinolin-2-ylbenzene-2-id-1-amine;2-[3-[2-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]propan-2-yl]benzene-2-id-1-yl]quinoline;2-[3-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]sulfanylbenzene-2-id-1-yl]quinoline;tetrakis(platinum(2+)) (PubChem CID 159007015) has the molecular formula C169H143N13OPt4S
and a molecular weight of 3184.47 g/mol. Its IUPAC name is 2-[3-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]oxybenzene-2-id-1-yl]quinoline;N-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]-N-phenyl-3-quinolin-2-ylbenzene-2-id-1-amine;2-[3-[2-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]propan-2-yl]benzene-2-id-1-yl]quinoline;2-[3-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]sulfanylbenzene-2-id-1-yl]quinoline;tetrakis(platinum(2+)).
Analyze 2-[3-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]oxybenzene-2-id-1-yl]quinoline;N-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]-N-phenyl-3-quinolin-2-ylbenzene-2-id-1-amine;2-[3-[2-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]propan-2-yl]benzene-2-id-1-yl]quinoline;2-[3-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]sulfanylbenzene-2-id-1-yl]quinoline;tetrakis(platinum(2+)) with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 2-[3-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]oxybenzene-2-id-1-yl]quinoline;N-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]-N-phenyl-3-quinolin-2-ylbenzene-2-id-1-amine;2-[3-[2-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]propan-2-yl]benzene-2-id-1-yl]quinoline;2-[3-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]sulfanylbenzene-2-id-1-yl]quinoline;tetrakis(platinum(2+))?
The IUPAC name of 2-[3-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]oxybenzene-2-id-1-yl]quinoline;N-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]-N-phenyl-3-quinolin-2-ylbenzene-2-id-1-amine;2-[3-[2-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]propan-2-yl]benzene-2-id-1-yl]quinoline;2-[3-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]sulfanylbenzene-2-id-1-yl]quinoline;tetrakis(platinum(2+)) (CID 159007015) is 2-[3-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]oxybenzene-2-id-1-yl]quinoline;N-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]-N-phenyl-3-quinolin-2-ylbenzene-2-id-1-amine;2-[3-[2-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]propan-2-yl]benzene-2-id-1-yl]quinoline;2-[3-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]sulfanylbenzene-2-id-1-yl]quinoline;tetrakis(platinum(2+)).
What is the SMILES notation for 2-[3-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]oxybenzene-2-id-1-yl]quinoline;N-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]-N-phenyl-3-quinolin-2-ylbenzene-2-id-1-amine;2-[3-[2-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]propan-2-yl]benzene-2-id-1-yl]quinoline;2-[3-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]sulfanylbenzene-2-id-1-yl]quinoline;tetrakis(platinum(2+))?
The canonical SMILES for 2-[3-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]oxybenzene-2-id-1-yl]quinoline;N-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]-N-phenyl-3-quinolin-2-ylbenzene-2-id-1-amine;2-[3-[2-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]propan-2-yl]benzene-2-id-1-yl]quinoline;2-[3-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]sulfanylbenzene-2-id-1-yl]quinoline;tetrakis(platinum(2+)) is CC(C)c1cccc(C(C)C)c1-n1c(-c2[c-]c(C(C)(C)c3[c-]c(-c4ccc5ccccc5n4)ccc3)ccc2)nc2ccccc21.CC(C)c1cccc(C(C)C)c1-n1c(-c2[c-]c(N(c3[c-]c(-c4ccc5ccccc5n4)ccc3)c3ccccc3)ccc2)nc2ccccc21.CC(C)c1cccc(C(C)C)c1-n1c(-c2[c-]c(Oc3[c-]c(-c4ccc5ccccc5n4)ccc3)ccc2)nc2ccccc21.CC(C)c1cccc(C(C)C)c1-n1c(-c2[c-]c(Sc3[c-]c(-c4ccc5ccccc5n4)ccc3)ccc2)nc2ccccc21.[Pt+2].[Pt+2].[Pt+2].[Pt+2].
What is the InChIKey of 2-[3-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]oxybenzene-2-id-1-yl]quinoline;N-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]-N-phenyl-3-quinolin-2-ylbenzene-2-id-1-amine;2-[3-[2-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]propan-2-yl]benzene-2-id-1-yl]quinoline;2-[3-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]sulfanylbenzene-2-id-1-yl]quinoline;tetrakis(platinum(2+))?
The InChIKey is MLQOBXCOBWSFKL-UHFFFAOYSA-N. The full InChI is InChI=1S/C46H38N4.C43H39N3.C40H33N3O.C40H33N3S.4Pt/c1-31(2)39-22-14-23-40(32(3)4)45(39)50-44-26-11-10-25-43(44)48-46(50)35-17-13-21-38(30-35)49(36-18-6-5-7-19-36)37-20-12-16-34(29-37)42-28-27-33-15-8-9-24-41(33)47-42;1-28(2)35-19-13-20-36(29(3)4)41(35)46-40-23-10-9-22-39(40)45-42(46)32-16-12-18-34(27-32)43(5,6)33-17-11-15-31(26-33)38-25-24-30-14-7-8-21-37(30)44-38;2*1-26(2)33-17-11-18-34(27(3)4)39(33)43-38-21-8-7-20-37(38)42-40(43)30-14-10-16-32(25-30)44-31-15-9-13-29(24-31)36-23-22-28-12-5-6-19-35(28)41-36;;;;/h5-28,31-32H,1-4H3;7-25,28-29H,1-6H3;2*5-23,26-27H,1-4H3;;;;/q4*-2;4*+2.
What are the key properties of 2-[3-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]oxybenzene-2-id-1-yl]quinoline;N-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]-N-phenyl-3-quinolin-2-ylbenzene-2-id-1-amine;2-[3-[2-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]propan-2-yl]benzene-2-id-1-yl]quinoline;2-[3-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]sulfanylbenzene-2-id-1-yl]quinoline;tetrakis(platinum(2+))?
2-[3-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]oxybenzene-2-id-1-yl]quinoline;N-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]-N-phenyl-3-quinolin-2-ylbenzene-2-id-1-amine;2-[3-[2-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]propan-2-yl]benzene-2-id-1-yl]quinoline;2-[3-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]sulfanylbenzene-2-id-1-yl]quinoline;tetrakis(platinum(2+)) has a molecular weight of 3184.47 g/mol, XLogP of 44.75, 29 rotatable bonds, 0 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[3-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]oxybenzene-2-id-1-yl]quinoline;N-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]-N-phenyl-3-quinolin-2-ylbenzene-2-id-1-amine;2-[3-[2-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]propan-2-yl]benzene-2-id-1-yl]quinoline;2-[3-[3-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]benzene-2-id-1-yl]sulfanylbenzene-2-id-1-yl]quinoline;tetrakis(platinum(2+)) is sourced from PubChem (CID 159007015), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).